NEW DELHI: Jubilant Life Sciences on Tuesday posted a 22.48% rise in consolidated net profit at ₹161.60 crore for the quarter ended June, on robust sales in pharmaceuticals. It had a net profit of ₹131.93 crore a year ago. “We have started the FY-17 on a positive note delivering strong performance in pharmaceuticals segment which contributed about 70% of the company’s operating profit,” chairman Shyam S Bhartia and co-chairman and MD Hari S Bhartia said in a statement.
{{^htLoading}} {{/htLoading}}
Stay updated with the latest Business News, stock market updates, petrol and diesel prices, gold and silver rates, income tax updates and major developments from India and across the world.
Stay updated with the latest Business News, stock market updates, petrol and diesel prices, gold and silver rates, income tax updates and major developments from India and across the world.
Advertisement
{{/htLoading}}{{#usCountry}}